Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study
Publication date: October 2026 Source: Journal of Cardiac Failure, Volume 32, Issue 10 Author(s): OLIVES NGUYEN, JACK WIEDRICK, DANIELE MASSERA, ELIZABETH ADLESTEIN, SUMAR FREJAT, MATTEO CASTRICHINI, SAID ALSIDAWI, JOHN R. GIUDICESSI, JEFFREY B. GESKE, RICHARD T. CARRICK, JOSE MADRAZO, NICOLE DELLISE, MARK A. ZENKER, THOMAS A. BOYLE, NOSHEEN REZA, ANJALI TIKU OWENS, DAVID S. FRANKEL, PRABHJOT HUNDAL, JAMIL TAJIK, PATRYCJA GALAZKA
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study. // Journal of Cardiac Failure. – URL: https://www.sciencedirect.com/science/article/pii/S1071916426001132?dgcid=rss_sd_all
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study. Journal of Cardiac Failure. https://www.sciencedirect.com/science/article/pii/S1071916426001132?dgcid=rss_sd_all
“Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.” Journal of Cardiac Failure.
@article{article117036,
title = {Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study},
journal = {Journal of Cardiac Failure},
url = {https://www.sciencedirect.com/science/article/pii/S1071916426001132?dgcid=rss_sd_all}
}